— Zika



Valneva and Emergent BioSolutions reported positive Phase 1 interim results for vaccine candidate against Zika virus


Learn more

— Media releases


December 17, 2018

Valneva Initiates Phase 2 Clinical Development for its Lyme Disease Vaccine Candidate

Read more


Please update your browser...